SKYX Platforms Corp. — Form 8-K Summary
Reporting date: September 28, 2026; filed October 1, 2026. The report concerns a board-member vacancy and Nasdaq governance-rule compliance, not operating results.
Business context and event
Independent director Efrat L. Greenstein Brayer passed away on September 26, 2026. She served on the audit and compensation committees and chaired the nominating and corporate governance committee.
Nasdaq compliance
- On September 28, the company notified Nasdaq that it was no longer compliant with the requirement for a majority-independent board and the requirement for an audit committee of at least three members.
- Nasdaq notified the company on September 30 that the cure period expires at the earlier of the next annual meeting or September 26, 2027. If the annual meeting is held before March 25, 2027, the company must demonstrate compliance by March 25, 2027.
- The company intends to take action to regain compliance but cautions that it cannot assure it will do so within the applicable cure period. The notice has no immediate effect on the Nasdaq listing, subject to continued compliance with listing rules.
Financial information and outlook
This 8-K provides no revenue, earnings, cash-flow, margin, debt, liquidity, or other financial metrics, and no financial guidance or operating outlook.
Important facts for investors to verify
- Whether and when the company appoints directors or makes other changes sufficient to restore board independence and audit committee size.
- The date of the next annual meeting and the applicable compliance deadline.
- Any subsequent Nasdaq notice or update on the company’s listing-rule compliance.